Director, Cath Labs and HCM Program
Westchester Medical Center
Valhalla, New York, United States
Dr. Srihari S. Naidu is an Interventional Cardiologist and Director of the Cardiac Cath Laboratories and Hypertrophic Cardiomyopathy Program at Westchester Medical Center. His main interests include hypertrophic cardiomyopathy and alcohol septal ablation, the use of percutaneous ventricular assist devices including in the treatment of cardiogenic shock, and the prevention of stroke with PFO closure and LAAO. He is a two termTrustee of SCAI, Founder of the SCAI ELM Program, and Trustee Emeritus of Brown University. He is also on the Board of Governors of ACC as the NY Chapter President, and serves on the NY State Cardiac Advisory Committee. He is an author on the HCM, SIHD and Perc VAD national guidelines, and Chaired the SCAI SHOCK Classification. He is Editor of the international textbook on Hypertrophic Cariomyopathy. Dr. Naidu is on the Executive Committee for SCAI and will be President of SCAI in 2025.
No relationships to disclose
One Size Doesn't Fit All: Right-Sizing the SCAI SHOCK Classification to Devices and Techniques
Sunday, March 10, 2024
8:08 AM – 8:16 AM ET
IMPLEMENTING CARDIOGENIC SHOCK INITIATIVES: BUILDING THE SHOCK TEAM
Sunday, March 10, 2024
10:42 AM – 11:38 AM ET
CARDIOGENIC SHOCK: PAST, PRESENT, AND FUTURE CLINICAL TRIALS
Sunday, March 10, 2024
11:38 AM – 12:25 PM ET
Sunday, March 10, 2024
12:10 PM – 12:25 PM ET
Mechanical Circulatory Support in Cardiogenic Shock – What’s the Data and What’s the Data in Women?
Monday, March 11, 2024
8:11 AM – 8:19 AM ET
Monday, March 11, 2024
8:19 AM – 8:27 AM ET
Monday, March 11, 2024
8:36 AM – 8:43 AM ET
Monday, March 11, 2024
8:49 AM – 8:55 AM ET
Live Case from Mount Sinai Hospital | New York, NY
Monday, March 11, 2024
2:00 PM – 2:50 PM ET
Alcohol Ablation or Mavacamten?
Monday, March 11, 2024
3:28 PM – 3:36 PM ET
Monday, March 11, 2024
4:40 PM – 5:15 PM ET
Keys to Successful Alcohol Ablation
Tuesday, March 12, 2024
11:30 AM – 11:38 AM ET